INS and COVID-19: The use of a flexible SC catheter can help to overcome this disadvantage of using SC insulin injection without affecting its efficacy.30 Moreover, the recent ISPAD guideline for management of DKA during COVID-19 raised concern about a possible increased burden on the nursing staff due to the frequent injections.17 In our study, the SC insulin group had their DKA resolved 2.83 hours sooner than the IV group, therefore saving nursing effort in extracting blood for laboratory monitoring and continuing DKA monitoring and management.11,31,32